logo
Sign in

NBY Stock Price, Chart, Stats & News

NovaBay Pharmaceuticals, Inc.
Save
39.14M
Market cap
Current P/E
Forward P/E
272.13%
Dividend yield

NBY chart

1M
3M
1Y
5Y
Loading chart...

About

NovaBay Pharmaceuticals, Inc. (NBY) is a pharmaceutical company that specializes in developing and globally distributing products for eyecare and dermatology. Its product portfolio includes Avenova, an advanced solution designed for cleaning the delicate skin around the eye, such as the eyelids, by removing foreign substances, microorganisms, and debris. The company also offers wound management solutions under its NeutroPhase and PhaseOne brands.

Similar securities

Based on sector and market capitalization

Report issue